Cunlong Zhang

744 total citations
32 papers, 641 citations indexed

About

Cunlong Zhang is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Cunlong Zhang has authored 32 papers receiving a total of 641 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 11 papers in Organic Chemistry and 11 papers in Oncology. Recurrent topics in Cunlong Zhang's work include Synthesis and biological activity (7 papers), Histone Deacetylase Inhibitors Research (7 papers) and Computational Drug Discovery Methods (5 papers). Cunlong Zhang is often cited by papers focused on Synthesis and biological activity (7 papers), Histone Deacetylase Inhibitors Research (7 papers) and Computational Drug Discovery Methods (5 papers). Cunlong Zhang collaborates with scholars based in China, Singapore and Macao. Cunlong Zhang's co-authors include Chunyan Tan, Yu Chen, Yuyang Jiang, Yuyang Jiang, Chunmei Gao, Zigao Yuan, Qinsheng Sun, Hongxia Liu, Xiaowu Chen and Shaopeng Chen and has published in prestigious journals such as Scientific Reports, Journal of Medicinal Chemistry and Molecules.

In The Last Decade

Cunlong Zhang

32 papers receiving 630 citations

Peers

Countries citing papers authored by Cunlong Zhang

Since Specialization

Citations

This map shows the geographic impact of Cunlong Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cunlong Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cunlong Zhang more than expected).

Fields of papers citing papers by Cunlong Zhang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cunlong Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cunlong Zhang. The network helps show where Cunlong Zhang may publish in the future.

Co-authorship network of co-authors of Cunlong Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Cunlong Zhang. A scholar is included among the top collaborators of Cunlong Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cunlong Zhang. Cunlong Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Dual inhibitors of DNMT and HDAC remodels the immune microenvironment of colorectal cancer and enhances the efficacy of anti-PD-L1 therapy 2024 ·Pharmacological Research ·(unknown), Bizhu Chu, (unknown), (unknown), Dawei Chen, (unknown), Wenjun Huang, Weiwen Fan, Qinyuan Li, Cunlong Zhang, Zigao Yuan, Jumin Huang, Elaine Lai‐Han Leung, Yuyang Jiang	18
2	Identification of the HECT domain binding of indole-3-carbinol (I3C) derivatives for breast cancer therapy 2023 ·Phytochemistry Letters ·Wenwen Zheng, Zhichao Shi, Xun Zhang, (unknown), Zigao Yuan, Lei Zhao, Qinyuan Li, Zixuan Qiu, Cunlong Zhang, Bizhu Chu, Zijian Liu, Wei‐Min Chen, Yuyang Jiang	3
3	Design, synthesis and antitumor evaluation of novel 1H-indole-2-carboxylic acid derivatives targeting 14-3-3η protein 2022 ·European Journal of Medicinal Chemistry ·(unknown), (unknown), Linbo Chen, (unknown), Vincent Kam Wai Wong, Dawei Chen, Zijian Liu, Yaoyao Zhou, Weibin Wu, Zixuan Qiu, Cunlong Zhang, Yuan Li, Yuyang Jiang	4
4	Quinazoline-based hydroxamic acid derivatives as dual histone methylation and deacetylation inhibitors for potential anticancer agents 2021 ·Bioorganic & Medicinal Chemistry ·(unknown), Qiuzi Dai, Zigao Yuan, Tingting Fan, Cunlong Zhang, Zijian Liu, Bizhu Chu, Qinsheng Sun, Yan Chen, Yuyang Jiang	17
5	Design, synthesis and evaluation of novel ErbB/HDAC multitargeted inhibitors with selectivity in EGFRT790M mutant cell lines 2021 ·European Journal of Medicinal Chemistry ·Lei Zhao, Tingting Fan, Zhichao Shi, Chao Ding, Cunlong Zhang, Zigao Yuan, Qinsheng Sun, Chunyan Tan, Bizhu Chu, Yuyang Jiang	18
6	Discovery of the PARP (poly ADP-ribose polymerase) inhibitor 2-(1-(4,4-difluorocyclohexyl)piperidin-4-yl)-1H-benzo[d]imidazole-4-carboxamide for the treatment of cancer 2021 ·Bioorganic Chemistry ·(unknown), Weibin Wu, Cunlong Zhang, Zhichao Shi, Dawei Chen, Xin Zhai, Yuyang Jiang	11
7	Synthesis and Anticancer Research of N ‐(2‐aminophenyl)benzamide Acridine Derivatives as Dual Topoisomerase I and Isoform‐Selective HDAC Inhibitors 2020 ·ChemistrySelect ·Bin Zhang, Qiting Zhang, (unknown), Ning Wang, Haixiao Jin, Feng Liu, Cunlong Zhang, Shan He	9
8	Discovery of triazolo [1,5-a] pyridine derivatives as novel JAK1/2 inhibitors 2020 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Weibin Wu, Cunlong Zhang, Zijian Liu, (unknown), Zigao Yuan, Anqi Li, Dawei Chen, Xin Zhai, Yuyang Jiang	3
9	Development of a versatile DNMT and HDAC inhibitor C02S modulating multiple cancer hallmarks for breast cancer therapy 2019 ·Bioorganic Chemistry ·Zigao Yuan, Shaopeng Chen, Chunmei Gao, Qiuzi Dai, Cunlong Zhang, Qinsheng Sun, Jin‐Shun Lin, Chun Guo, Yu Chen, Yuyang Jiang	48
10	Antiproliferative activities of the second-generation antipsychotic drug sertindole against breast cancers with a potential application for treatment of breast-to-brain metastases 2018 ·Scientific Reports ·Wei Zhang, Cunlong Zhang, Feng Liu, Yu Mao, Wei Xu, Tingting Fan, Qinsheng Sun, Shengnan He, Yu Chen, Wei Guo, (unknown), Yuyang Jiang	25
11	Novel multi-substituted benzyl acridone derivatives as survivin inhibitors for hepatocellular carcinoma treatment 2017 ·European Journal of Medicinal Chemistry ·Bin Zhang, Ning Wang, Cunlong Zhang, Chunmei Gao, Wei Zhang, Kang Chen, Weibin Wu, Yu Chen, Chunyan Tan, Feng Liu, Yuyang Jiang	37
12	Synthesis and investigation of novel 6-(1,2,3-triazol-4-yl)-4-aminoquinazolin derivatives possessing hydroxamic acid moiety for cancer therapy 2016 ·Bioorganic & Medicinal Chemistry ·Chao Ding, Shaopeng Chen, Cunlong Zhang, Guangnan Hu, Wei Zhang, Lulu Li, Yu Chen, Chunyan Tan, Yuyang Jiang	47
13	Clustered Distribution of Natural Product Leads of Drugs in the Chemical Space as Influenced by the Privileged Target-Sites 2015 ·Scientific Reports ·Lin Tao, Feng Zhu, Qin Chu, Cheng Zhang, Shangying Chen, Peng Zhang, Cunlong Zhang, Chunyan Tan, Chunmei Gao, (unknown), Yuyang Jiang, Yu Chen	18
14	A real-time fluorescence turn-on assay for trypsin based on a conjugated polyelectrolyte 2013 ·Journal of Materials Chemistry B ·(unknown), Ying Tan, Cunlong Zhang, Jiatao Wu, Lin Mei, Yuyang Jiang, Chunyan Tan	19
15	Development and experimental test of support vector machines virtual screening method for searching Src inhibitors from large compound libraries 2012 ·Chemistry Central Journal ·(unknown), Xiaohua Ma, Ruiying Zhao, Jingxian Zhang, Xiaona Wei, Xianghui Liu, Xin Liu, Cunlong Zhang, Chunyan Tan, Yuyang Jiang, Yu Chen	5
16	Selective VEGFR Inhibitors for Anticancer Therapeutics in Clinical Use and Clinical Trials 2012 ·Current Pharmaceutical Design ·Cunlong Zhang, Chunyan Tan, Huaiwei Ding, (unknown), Yuyang Jiang	22
17	An effective method for de novo peptide sequencing based on phosphorylation strategy and mass spectrometry 2011 ·Talanta ·Dongmei Zhang, Hongxia Liu, Shusheng Zhang, Xiaolan Chen, Shangfu Li, Cunlong Zhang, Xiangming Hu, Kaishun Bi, Xiaohong Chen, Yuyang Jiang	11
18	Exploration of (S)-3-aminopyrrolidine as a potentially interesting scaffold for discovery of novel Abl and PI3K dual inhibitors 2011 ·European Journal of Medicinal Chemistry ·Cunlong Zhang, Chunyan Tan, Xuyu Zu, Xin Zhai, Feng Liu, Bizhu Chu, Xiaohua Ma, Yu Chen, Ping Gong, Yuyang Jiang	43
19	Design and Synthesis of N-phosphoryl Peptide Modified Podophyllotoxin Derivatives as Potent Anticancer Agents 2011 ·Protein and Peptide Letters ·Xiangming Hu, Chunmei Gao, Chunyan Tan, Cunlong Zhang, Hualin Zhang, Shangfu Li, Hongxia Liu, Yuyang Jiang	7
20	Discovery of benzimidazole derivatives as novel multi-target EGFR, VEGFR-2 and PDGFR kinase inhibitors 2011 ·Bioorganic & Medicinal Chemistry ·Yunqi Li, Chunyan Tan, Chunmei Gao, Cunlong Zhang, Xudong Luan, Xiaowu Chen, Hongxia Liu, Yu Chen, Yuyang Jiang	105

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact